Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

The treatment might help COVID-19 related hair loss, but more research is needed.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

COVID-19 causes more taste, smell, hair, memory, and concentration issues than other respiratory infections.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 can cause long-lasting non-respiratory symptoms, especially in women.

COVID-19 pandemic increased alopecia areata cases and hospitalizations.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

More symptoms during initial COVID infection increase the risk of long-term effects.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Some early COVID-19 mutations in patients predicted future common virus mutations.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

About 61% of women who had COVID-19 experienced hair loss afterward.